The effectiveness of mouthwash against SARS-CoV-2 infection: A review of scientific and clinical evidence

Liu, 2020, Community transmission of severe acute respiratory syndrome coronavirus 2, Shenzhen, China, 2020, Emerg Infect Dis, 26, 1320, 10.3201/eid2606.200239 Zou, 2020, SARS-CoV-2 viral load in upper respiratory specimens of infected patients, N Engl J Med, 382, 1177, 10.1056/NEJMc2001737 To, 2020, Consistent detection of 2019 novel coronavirus in saliva, Clin Infect Dis, 71, 841, 10.1093/cid/ciaa149 Xu, 2020, High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa, Int J Oral Sci, 12, 8, 10.1038/s41368-020-0074-x Liu, 2020, Viral dynamics in mild and severe cases of COVID-19, Lancet Infect Dis, 20, 656, 10.1016/S1473-3099(20)30232-2 Mateos-Moreno, 2021, Oral antiseptics against coronavirus: in-vitro and clinical evidence, J Hosp Infect, 113, 30, 10.1016/j.jhin.2021.04.004 Carrouel, 2021, Antiviral activity of reagents in mouth rinses against SARS-CoV-2, J Dent Res, 100, 124, 10.1177/0022034520967933 Pratelli, 2015, Role of the lipid rafts in the life cycle of canine coronavirus, J Gen Virol, 96, 331, 10.1099/vir.0.070870-0 Siddharta, 2017, Virucidal activity of world health organization-recommended formulations against enveloped viruses, including Zika, ebola, and emerging coronaviruses, J Infect Dis, 215, 902, 10.1093/infdis/jix046 Kampf, 2020, Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents, J Hosp Infect, 104, 246, 10.1016/j.jhin.2020.01.022 O'Donnell, 2020, Potential role of oral rinses targeting the viral lipid envelope in SARS-CoV-2 infection, Function (Oxf), 1, zqaa002, 10.1093/function/zqaa002 Stathis, 2021, Review of the use of nasal and oral antiseptics during a global pandemic, Future Microbiol, 16, 119, 10.2217/fmb-2020-0286 Kratzel, 2020, Inactivation of severe acute respiratory syndrome coronavirus 2 by WHO-recommended hand rub formulations and alcohols, Emerg Infect Dis, 26, 1592, 10.3201/eid2607.200915 Chopra, 2021, Can povidone iodine gargle/mouthrinse inactivate SARS-CoV-2 and decrease the risk of nosocomial and community transmission during the COVID-19 pandemic? An evidence-based update, Jpn Dent Sci Rev, 57, 39, 10.1016/j.jdsr.2021.03.001 Cavalcante-Leao, 2021, Is there scientific evidence of the mouthwashes effectiveness in reducing viral load in Covid-19? A systematic review, J Clin Exp Dent, 13, e179, 10.4317/jced.57406 Castro-Ruiz, 2020, Povidone-Iodine Solution: a potential antiseptic to minimize the risk of COVID-19? A narrative review, J Int Soc Prev Community Dent, 10, 681, 10.4103/jispcd.JISPCD_304_20 Chorney, 2020, Considerations for povidone-iodine antisepsis in pediatric nasal and pharyngeal surgery during the COVID-19 pandemic, Am J Otolaryngol, 41, 102737, 10.1016/j.amjoto.2020.102737 Meyers, 2021, Lowering the transmission and spread of human coronavirus, J Med Virol, 93, 1605, 10.1002/jmv.26514 Pelletier, 2021, Efficacy of povidone-Iodine nasal and oral antiseptic preparations against severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), Ear Nose Throat J, 100, 192S, 10.1177/0145561320957237 Jain, 2021, Chlorhexidine: an effective anticovid mouth rinse, J Indian Soc Periodontol, 25, 86, 10.4103/jisp.jisp_824_20 Hassandarvish, 2020, In vitro virucidal activity of povidone iodine gargle and mouthwash against SARS-CoV-2: implications for dental practice, Br Dent J, 1 Davies, 2021, Effective in vitro inactivation of SARS-CoV-2 by commercially available mouthwashes, J Gen Virol, 102 Meister, 2020, Virucidal efficacy of different oral rinses against severe acute respiratory syndrome coronavirus 2, J Infect Dis, 222, 1289, 10.1093/infdis/jiaa471 Seneviratne, 2021, Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore, Infection, 49, 305, 10.1007/s15010-020-01563-9 Guenezan, 2021, Povidone iodine mouthwash, gargle, and nasal spray to reduce nasopharyngeal viral load in patients with COVID-19: a randomized clinical trial, JAMA Otolaryngol Head Neck Surg, 147, 400, 10.1001/jamaoto.2020.5490 Baker, 2020, Repurposing quaternary ammonium compounds as potential treatments for COVID-19, Pharm Res (N Y), 37, 104, 10.1007/s11095-020-02842-8 Munoz-Basagoiti J, Perez-Zsolt D, Leon R, Blanc V, Raich-Regue D, Cano-Sarabia M, et al. Mouthwashes with CPC reduce the infectivity of SARS-CoV-2 variants in vitro. J Dent Res 2021220345211029269. Komine, 2021, Virucidal activity of oral care products against SARS-CoV-2 in vitro, J Oral Maxillofac Surg Med Pathol, 33, 475, 10.1016/j.ajoms.2021.02.002 Eduardo, 2021, Salivary SARS-CoV-2 load reduction with mouthwash use: a randomized pilot clinical trial, Heliyon, 7, 10.1016/j.heliyon.2021.e07346 Reis, 2021, Can preprocedural mouthrinses reduce SARS-CoV-2 load in dental aerosols?, Med Hypotheses, 146, 110436, 10.1016/j.mehy.2020.110436 Testori, 2020, COVID-19 and oral surgery: a narrative review of preoperative mouth rinses, Acta Stomatol Croat, 54, 431, 10.15644/asc54/4/10 Moosavi, 2020, Antiviral mouthwashes: possible benefit for COVID-19 with evidence-based approach, J Oral Microbiol, 12, 1794363, 10.1080/20002297.2020.1794363 Bernstein, 1990, In vitro virucidal effectiveness of a 0.12%-chlorhexidine gluconate mouthrinse, J Dent Res, 69, 874, 10.1177/00220345900690030901 Steinhauer, 2021, Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476, J Hosp Infect, 111, 180, 10.1016/j.jhin.2021.01.031 Huang, 2021, Use of chlorhexidine to eradicate oropharyngeal SARS-CoV-2 in COVID-19 patients, J Med Virol, 93, 4370, 10.1002/jmv.26954 Gottsauner, 2020, A prospective clinical pilot study on the effects of a hydrogen peroxide mouthrinse on the intraoral viral load of SARS-CoV-2, Clin Oral Invest, 24, 3707, 10.1007/s00784-020-03549-1 Di Domenico, 2021, Effectiveness of hydrogen peroxide as auxiliary treatment for hospitalized COVID-19 patients in Brazil: preliminary results of a randomized double-blind clinical trial, Epidemiol Health, 43, 10.4178/epih.e2021032 Dennison, 1995, The antiviral spectrum of Listerine antiseptic, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 79, 442, 10.1016/S1079-2104(05)80124-6 Carrouel, 2021, Use of an antiviral mouthwash as a barrier measure in the SARS-CoV-2 transmission in adults with asymptomatic to mild COVID-19: a multicentre, randomized, double-blind controlled trial, Clin Microbiol Infect, 27, 1494, 10.1016/j.cmi.2021.05.028 Prescott, 2020, Corticosteroids in COVID-19 ARDS: evidence and hope during the pandemic, J Am Med Assoc, 324, 1292, 10.1001/jama.2020.16747 Schurmann, 2021, Mouthrinses against SARS-CoV-2: anti-inflammatory effectivity and a clinical pilot study, Eur Arch Oto-Rhino-Laryngol, 1 Samaranayake, 2021, The efficacy of bio-aerosol reducing procedures used in dentistry: a systematic review, Acta Odontol Scand, 79, 69, 10.1080/00016357.2020.1839673